GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,853 | -633 | -371 | -501 | -147 |
| Depreciation Amortization | 1,637 | 190 | 121 | 691 | 641 |
| Accounts receivable | N/A | 35 | 10 | -40 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 84 | N/A | N/A |
| Other Working Capital | 387 | 230 | 88 | 477 | 484 |
| Other Operating Activity | 2,118 | 45 | -22 | -1,069 | -1,051 |
| Operating Cash Flow | $-711 | $-133 | $-90 | $-442 | $-73 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 35 |
| Debt Issued | N/A | 89 | 50 | 433 | N/A |
| Debt Repayment | 1,329 | N/A | N/A | -8 | -34 |
| Financing Cash Flow | $1,329 | $89 | $50 | $425 | $1 |
| Beginning Cash Position | 43 | 43 | 43 | 123 | 123 |
| End Cash Position | 664 | 1 | 4 | 43 | N/A |
| Net Cash Flow | $621 | $-42 | $-39 | $-80 | $-123 |
| Free Cash Flow | |||||
| Operating Cash Flow | -711 | -133 | -90 | -442 | -73 |
| Free Cash Flow | -711 | -133 | -90 | -442 | -73 |